204 related articles for article (PubMed ID: 32265227)
1. Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.
Moshkovich N; Ochoa HJ; Tang B; Yang HH; Yang Y; Huang J; Lee MP; Wakefield LM
Cancer Res; 2020 Jun; 80(11):2125-2137. PubMed ID: 32265227
[TBL] [Abstract][Full Text] [Related]
2. Endogenous PAD4 in Breast Cancer Cells Mediates Cancer Extracellular Chromatin Network Formation and Promotes Lung Metastasis.
Shi L; Yao H; Liu Z; Xu M; Tsung A; Wang Y
Mol Cancer Res; 2020 May; 18(5):735-747. PubMed ID: 32193354
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1.
Dong S; Zhang Z; Takahara H
Mol Endocrinol; 2007 Jul; 21(7):1617-29. PubMed ID: 17456793
[TBL] [Abstract][Full Text] [Related]
4. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization.
Wang Y; Lyu Y; Tu K; Xu Q; Yang Y; Salman S; Le N; Lu H; Chen C; Zhu Y; Wang R; Liu Q; Semenza GL
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34452909
[TBL] [Abstract][Full Text] [Related]
5. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract][Full Text] [Related]
6. Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53.
Ahn YT; Kim MS; Kim YS; An WG
Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33233699
[TBL] [Abstract][Full Text] [Related]
7. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Promoted Proliferation of Osteosarcoma by Peptidylarginine Deiminase 4.
Guo J; Yin L; Zhang X; Su P; Zhai Q
Biomed Res Int; 2021; 2021():5596014. PubMed ID: 34055985
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
10. Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation.
Zhai Q; Wang L; Zhao P; Li T
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):567-572. PubMed ID: 28472221
[TBL] [Abstract][Full Text] [Related]
11. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.
Zhang X; Gamble MJ; Stadler S; Cherrington BD; Causey CP; Thompson PR; Roberson MS; Kraus WL; Coonrod SA
PLoS Genet; 2011 Jun; 7(6):e1002112. PubMed ID: 21655091
[TBL] [Abstract][Full Text] [Related]
13. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
14. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
15. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis of PADI4 target genes during multi-lineage differentiation of embryonic stem cells.
Singh AK; Khan S; Moore D; Andrews S; Christophorou MA
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220236. PubMed ID: 37778387
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
Almozyan S; Colak D; Mansour F; Alaiya A; Al-Harazi O; Qattan A; Al-Mohanna F; Al-Alwan M; Ghebeh H
Int J Cancer; 2017 Oct; 141(7):1402-1412. PubMed ID: 28614911
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 7-mediated
Chen TY; Lee SH; Dhar SS; Lee MG
J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
[TBL] [Abstract][Full Text] [Related]
20. PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation.
Kolodziej S; Kuvardina ON; Oellerich T; Herglotz J; Backert I; Kohrs N; Buscató El; Wittmann SK; Salinas-Riester G; Bonig H; Karas M; Serve H; Proschak E; Lausen J
Nat Commun; 2014 May; 5():3995. PubMed ID: 24874575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]